KHS
Articles
- Page Path
- HOME > Korean J Headache > Volume 24(1); 2023 > Article
- Reiview Article 자베게판트: 급성기 편두통 치료의 코투여 약물
- 서종근
- Zavegepant: Intranasal Drug for Acute Migraine Treatment
- Jong-Geun Seo
-
Korean Journal of Headache 2023;24(1):17-19
Published online: June 30, 2023
경북대학교 의과대학 신경과학교실
Department of Neurology, School of Medicine, Kyungpook National University, Daegu, Korea
Department of Neurology, School of Medicine, Kyungpook National University, Daegu, Korea
-
Corresponding author:
Jong-Geun Seo, Tel: +82-53-420-5770, Fax: +82-53-422-4265,
Email: jonggeun.seo@gmail.com
Received: 25 May 2023 • Revised: 14 June 2023 • Accepted: 19 June 2023
- 125 Views
- 7 Download
- 0 Crossref
- 0 Scopus
Abstract
Calcitonin gene-related peptide (CGRP) is probably the most potent vasodilator in cerebral circulation. The new CGRP-targeted therapy for the treatment of acute treatment are now available for clinical practice. This review article summarized efficacy and safety of zavegepant, which is the first intranasal small molecule CGRP receptor antagonist for acute migraine treatment.
Cited- Related articles
TOP
